Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity

Published:2020-02 Issue:2 Volume:10 Page:358-373
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Deng Huan,Tan Songwei,Gao Xueqin,Zou Chenming,Xu Chenfeng,Tu Kun,Song Qingle,Fan Fengjuan,Huang Wei,Zhang Zhiping

Funder

National Natural Science Foundation of China

Wuhan University of Science and Technology

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference49 articles.

1. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat Med,2002

2. PD-1 and its ligands in tolerance and immunity;Keir;Annu Rev Immunol,2008

3. Colocalization of inflammatory response with B7-H1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape;Taube;Sci Transl Med,2012

4. Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells;Spranger;Sci Transl Med,2013

5. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells;Selby;Canc Immunol Res,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects;Current Gene Therapy;2024-10

2. The era of genome editing: current updates and the status of food and nutrition security;Frontiers in Sustainability;2024-08-13

3. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment;Nanotechnology;2024-07-17

4. CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-22

5. Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer;ACS Biomaterials Science & Engineering;2024-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3